PIM
SAGE

Partner Investment Management’s Sage Therapeutics SAGE Stock Holding History

Partner Investment Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,267
Closed -$599K – 61
2019
Q3 		$599K Buy
+4,267
New +$714K 1.03% 38
2019
Q2 		– Sell
-2,138
Closed -$340K – 94
2019
Q1 		$340K Sell
2,138
-4,046
-65% -$586K 0.39% 66
2018
Q4 		$592K Buy
+6,184
New +$708K 0.74% 45
2017
Q2 		– Sell
-1,572
Closed -$112K – 102
2017
Q1 		$112K Buy
+1,572
New +$92.1K 0.14% 89
2016
Q2 		– Sell
-4,201
Closed -$135K – 98
2016
Q1 		$135K Buy
+4,201
New +$148K 0.22% 73

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Partner Investment Management's SAGE Position: Q4 2019 in Review

Partner Investment Management sold out of Sage Therapeutics (SAGE) in Q4 2019, closing a stake of 4,267 shares — an estimated $599K sold.

Partner Investment Management first reported a position in SAGE in Q1 2016 and held it in 5 quarters. The position peaked at $599K in Q3 2019. 267 funds tracked by Wall St. Rank hold SAGE as of Q4 2019.

  • Partner Investment Management reported no remaining Sage Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Partner Investment Management sold 4,267 Sage Therapeutics shares in Q4 2019, an estimated $599K.
  • Partner Investment Management first reported a position in Sage Therapeutics in Q1 2016 and held it in 5 quarters.
  • Partner Investment Management's Sage Therapeutics position peaked at $599K in Q3 2019.
  • 267 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2019.

Based on Partner Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.